TR4 on Thyroid Ultrasound
TR4 indicates a "moderately suspicious" thyroid nodule with a 4-6 point score on the ACR TI-RADS classification system, carrying a 5-20% malignancy risk and requiring fine-needle aspiration (FNA) biopsy only if the nodule measures ≥1.5 cm. 1
Understanding the TR4 Classification
TR4 is part of the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS), which stratifies thyroid nodules into five risk categories (TR1-TR5) based on a point-scoring system. The system assigns points across five ultrasound feature categories:
- Composition (0-2 points)
- Echogenicity (0-3 points)
- Shape (0-3 points)
- Margin (0-3 points)
- Echogenic foci (0-3 points)
A nodule scoring 4-6 total points is classified as TR4 (moderately suspicious). 1
Clinical Management of TR4 Nodules
Size-Based Biopsy Thresholds
The ACR TI-RADS deliberately sets higher size thresholds than other guidelines to reduce unnecessary biopsies while maintaining safety:
- FNA recommended if ≥1.5 cm 1
- Ultrasound follow-up if ≥0.5 cm but <1.5 cm 1
- No action needed if <0.5 cm
This conservative approach reflects the understanding that not every thyroid malignancy requires detection, particularly small indolent cancers that may never cause clinical harm. 1
Follow-Up Protocol for TR4 Nodules Below Biopsy Threshold
For TR4 nodules measuring 0.5-1.4 cm, the ACR recommends surveillance ultrasound at 1,2,3, and 5 years. 1 Imaging can stop at 5 years if the nodule remains stable, as this reliably indicates benign behavior. 1
Significant growth is defined as:
- 20% increase in at least two dimensions AND minimal 2 mm increase, OR
- ≥50% volume increase 1
Diagnostic Performance
The ACR TI-RADS demonstrates higher specificity compared to ATA guidelines (pooled specificity approximately 77-84% vs. 46-63%), meaning it reduces unnecessary biopsies while maintaining reasonable sensitivity. 2 This is particularly valuable for TR4 nodules, where the moderate suspicion level requires careful risk-benefit assessment.
Key Ultrasound Features in TR4 Nodules
The most diagnostically valuable features for TR4 nodules include:
- Margin characteristics (irregular or lobulated margins) - highest diagnostic accuracy across all nodule sizes 3
- Hypoechogenicity (2 points)
- Solid or predominantly solid composition (2 points)
- Punctate echogenic foci (3 points)
Important caveat: Diagnostic accuracy varies by nodule size. For nodules ≤1 cm, interobserver agreement is lower (Kappa = 0.225) compared to nodules >1 cm (Kappa = 0.432), meaning smaller TR4 nodules are harder to characterize consistently. 3
Reducing Unnecessary Biopsies
For TR4 nodules at or above the 1.5 cm threshold, additional imaging modalities can help refine risk assessment:
Strain elastography combined with Virtual Touch tissue imaging quantification (SE + VTIQ) achieves:
- 82.1% sensitivity
- 83.5% specificity
- 80.2% accuracy
- Can reduce unnecessary biopsies while maintaining diagnostic performance 4
Critical Clinical Points
All nodules can be classified using ACR TI-RADS - unlike ATA guidelines which fail to categorize 4.4-17.9% of nodules (of which 5.6-56.1% prove malignant), the ACR system provides specific instructions for assigning points when features cannot be determined. 2
Multiple nodules: If multiple TR4 nodules meet biopsy criteria, target the two with highest point totals, not necessarily the largest. Size should not be the primary criterion. 1
The TR4 category balances cancer detection against overdiagnosis, recognizing that the sharp rise in thyroid cancer diagnosis has not improved long-term mortality outcomes, suggesting many detected cancers are clinically insignificant. 1